All In MedTech

Device Trial Radar · NCT01663051

Evaluation of the Zilver® Vena™ Venous Stent

Last checked: Nov 20, 2026Latest source record: Nov 1, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

35

Actual

Start

Nov 2012

Primary completion

Jul 2016

Study completion Jul 2016

Sponsor

Lead sponsor
Cook Group IncorporatedNot on our public-company list
Sponsor type
Industry
First posted
Aug 13, 2012

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This prospective, non-randomized, multi-center study is intended to evaluate the Zilver® Vena™ stent in the treatment of symptomatic iliofemoral venous outflow obstruction.

Conditions

  • Iliofemoral Venous Outflow Obstruction

Interventions

  • Zilver Vena Venous StentDevice

    Stenting iliofemoral venous outflow obstruction

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Major Adverse EventsTime frame: 1 month
  2. PatencyTime frame: 12 months

Locations

5 sites in 5 countries. Site status is shown where the registry gives one.

  • Klinikum Arnsberg GmbH

    Arnsberg, Germany

  • Galway University Hospitals

    Galway, Ireland

  • Hospital Madrid Monteprincipe

    Madrid, Spain

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.